Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 19 de 19
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Int J Obstet Anesth ; 31: 108-109, 2017 05.
Article de Anglais | MEDLINE | ID: mdl-28623090
2.
Int J Obstet Anesth ; 29: 18-25, 2017 Feb.
Article de Anglais | MEDLINE | ID: mdl-27720613

RÉSUMÉ

BACKGROUND: During spinal anesthesia for cesarean delivery phenylephrine is the vasopressor of choice but can cause bradycardia. Norepinephrine has both ß- and α-adrenergic activity suitable for maintaining blood pressure with less bradycardia. We hypothesized that norepinephrine would be superior to phenylephrine, requiring fewer rescue bolus interventions to maintain blood pressure. METHODS: Eighty-five parturients having spinal anesthesia for elective cesarean delivery were randomized to Group P (phenylephrine 0.1µg/kg/min) or Group N (norepinephrine 0.05µg/kg/min) fixed-rate infusions. Rescue bolus interventions of phenylephrine 100µg for hypotension, or ephedrine 5mg for bradycardia with hypotension, were given as required to maintain systolic blood pressure. Maternal hemodynamic variables were measured non-invasively. RESULTS: There was no difference between groups in the proportion of patients who required rescue vasopressor boluses (Group P: 65.8% [n=25] vs. Group N: 48.8% [n=21], P=0.12). The proportion of patients who received ⩾1 bolus of phenylephrine was similar between groups (Group P: 52.6% [n=20] vs. Group N: 46.5% [n=20], P=0.58). However, more patients received ⩾1 bolus of ephedrine in the phenylephrine group (Group P: 23.7% [n=9] vs. Group N: 2.3% [n=1], P<0.01). The incidence of emesis was greater in the phenylephrine group (Group P: 26.3% vs. Group P: 16.3%, P<0.001). Hemodynamic parameters including heart rate, the incidence of bradycardia, blood pressure, cardiac output, cardiac index, stroke volume, and systemic vascular resistance and neonatal outcome were similar between groups (all P<0.05). CONCLUSION: Norepinephrine fixed-rate infusion has efficacy for preventing hypotension and can be considered as an alternative to phenylephrine.


Sujet(s)
Anesthésie obstétricale/effets indésirables , Rachianesthésie/effets indésirables , Césarienne/effets indésirables , Hypotension artérielle/prévention et contrôle , Norépinéphrine/usage thérapeutique , Phényléphrine/usage thérapeutique , Adulte , Femelle , Humains , Perfusions veineuses , Grossesse , Résultat thérapeutique , Vasoconstricteurs/usage thérapeutique
3.
Neurology ; 73(12): 970-7, 2009 Sep 22.
Article de Anglais | MEDLINE | ID: mdl-19770473

RÉSUMÉ

BACKGROUND: The neuropeptide calcitonin gene-related peptide (CGRP) plays a key role in migraine pathophysiology. In this large phase 3 clinical trial, we sought to confirm the efficacy of telcagepant, the first orally bioavailable CGRP receptor antagonist. METHODS: Adults with migraine with or without aura (International Headache Society criteria) treated a moderate or severe attack with oral telcagepant 50 mg (n = 177), 150 mg (n = 381), 300 mg (n = 371), or placebo (n = 365) in a randomized, double-blind trial. The 5 co-primary endpoints were pain freedom, pain relief, and absence of photophobia, absence of phonophobia, and absence of nausea, all at 2 hours postdose. The key secondary endpoint was 2-24 hour sustained pain freedom. The prespecified primary efficacy analyses evaluated the 150 mg and 300 mg groups; the 50-mg group was included on an exploratory basis to further characterize the dose response but was not prespecified for analysis. Tolerability was assessed by adverse experience reports. RESULTS: Telcagepant 300 mg was more effective (p

Sujet(s)
Azépines/administration et posologie , Antagonistes du récepteur du peptide relié au gène de la calcitonine , Peptide relié au gène de la calcitonine/antagonistes et inhibiteurs , Imidazoles/administration et posologie , Migraines/traitement médicamenteux , Maladie aigüe , Adulte , Azépines/effets indésirables , Peptide relié au gène de la calcitonine/métabolisme , Relation dose-effet des médicaments , Méthode en double aveugle , Détermination du point final , Femelle , Humains , Hyperacousie/traitement médicamenteux , Hyperacousie/étiologie , Imidazoles/effets indésirables , Mâle , Adulte d'âge moyen , Migraines/métabolisme , Migraines/physiopathologie , Nausée/étiologie , , Mesure de la douleur , Photophobie/traitement médicamenteux , Photophobie/étiologie , Placebo , Qualité de vie , Récepteurs du peptide relié au gène de la calcitonine/métabolisme , Enquêtes et questionnaires , Résultat thérapeutique
4.
Cephalalgia ; 29(7): 711-8, 2009 Jul.
Article de Anglais | MEDLINE | ID: mdl-19210513

RÉSUMÉ

This study examined the effect of age on placebo response rates in rizatriptan trials in adults. Data from eight rizatriptan adult trials involving patients treating moderate/severe migraine attacks with rizatriptan 5 mg (N = 1819), rizatriptan 10 mg (N = 2046) or placebo (N = 1322) were pooled for post hoc analysis. Logistic regression was used to model 2-h pain relief (reduction to mild or none) and 2-h pain freedom rates by treatment groups. Older patients had lower placebo response rates than younger patients; the estimated odds ratio (older vs. younger) for a 10-year age increase was 0.83 for pain relief [95% confidence interval (CI) 0.75, 0.93] and 0.81 for pain freedom (95% CI 0.68, 0.97). The response proportion vs. age trend was flat for rizatriptan 5 mg and slightly increased for rizatriptan 10 mg. The treatment-by-age interaction was significant for pain relief (P < 0.001) and pain freedom (P = 0.001), suggesting an increasing trend of treatment advantage of rizatriptan over placebo as age increased. Age appeared to be an important predictor of placebo response rate in rizatriptan trials, with older patients being less likely to respond to placebo and more likely to respond to rizatriptan.


Sujet(s)
Migraines/traitement médicamenteux , Agonistes des récepteurs de la sérotonine/usage thérapeutique , Triazoles/usage thérapeutique , Tryptamines/usage thérapeutique , Adolescent , Adulte , Facteurs âges , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Effet placebo , Essais contrôlés randomisés comme sujet , Jeune adulte
6.
Neurol Sci ; 28 Suppl 2: S179-83, 2007 May.
Article de Anglais | MEDLINE | ID: mdl-17508167

RÉSUMÉ

Caffeine is the most widely consumed psychostimulant drug. It is a potent antagonist of adenosine receptors at dosages consistent with common dietary intake. With infrequent exposure, caffeine may act as an analgesic for headache or an adjuvant for the actions of other analgesics. With chronic repetitive intake, caffeine is associated with an increased risk of development of analgesicoveruse headache, chronic daily headache and physical dependency. Cessation of caffeine use following chronic exposures leads to a withdrawal syndrome, with headache as a dominant symptom.


Sujet(s)
Caféine/effets indésirables , Céphalées secondaires/induit chimiquement , Céphalées secondaires/physiopathologie , Céphalées/induit chimiquement , Céphalées/physiopathologie , Syndrome de sevrage/physiopathologie , Adénosine/métabolisme , Encéphale/effets des médicaments et des substances chimiques , Encéphale/métabolisme , Encéphale/physiopathologie , Association médicamenteuse , Synergie des médicaments , Céphalées/traitement médicamenteux , Céphalées secondaires/traitement médicamenteux , Humains , Agonistes des récepteurs purinergiques P1 , Récepteurs purinergiques P1/métabolisme , Syndrome de sevrage/métabolisme
7.
Cytogenet Genome Res ; 98(1): 29-37, 2002.
Article de Anglais | MEDLINE | ID: mdl-12584438

RÉSUMÉ

Oculodentodigital dysplasia (ODDD) is an autosomal dominant condition with congenital anomalies of the craniofacial and limb regions and neurodegeneration. Genetic anticipation for the dysmorphic and neurologic features has been inferred in a few families. Our previous linkage studies have refined the ODDD candidate region to chromosome 6q22-->q23. In an attempt to clone the ODDD gene, we created a yeast artificial chromosome contig with 31 redundant clones spanning the region and identified and ordered candidate genes and markers. Fluorescent IN SITU hybridization mapped two of these YAC clones to chromosome 6q22.2 telomeric to a known 6q21 fragile site, excluding it as a possible cause of the suggested anticipation. We performed mutation analysis on thirteen candidate genes - GRIK2, HDAC2, COL10A1, PTD013, KPNA5, PIST, ROS1, BRD7, PLN, HSF2, PKIB, FABP7, and HEY2. Although no mutations were found, we identified 44 polymorphisms, including 28 single nucleotide polymorphisms. Direct cDNA selection was performed and fifty-five clones were found to contain sequences that were not previously reported as known genes or ESTs. These clones and polymorphisms will assist in the further characterization of this region and identification of disease genes.


Sujet(s)
Malformations multiples/génétique , Chromosomes humains de la paire 6 , ADN/génétique , Marqueurs génétiques , Polymorphisme génétique , Protéines/génétique , Séquence nucléotidique , Cartographie chromosomique , Chromosomes artificiels de levure/génétique , Amorces ADN , Étiquettes de séquences exprimées , Malformations oculaires/génétique , Humains , Hybridation fluorescente in situ , Dégénérescence nerveuse/génétique , Odontodysplasie/génétique , Réaction de polymérisation en chaîne
8.
Hypertension ; 36(4): 553-60, 2000 Oct.
Article de Anglais | MEDLINE | ID: mdl-11040235

RÉSUMÉ

Sympathotonic orthostatic hypotension (SOH) is an idiopathic syndrome characterized by tachycardia, hypotension, elevated plasma norepinephrine, and symptoms of orthostatic intolerance provoked by assumption of an upright posture. We studied a woman with severe progressive SOH with blood pressure unresponsive to the pressor effects of alpha(1)-adrenergic receptor (AR) agonists. We tested the hypothesis that a circulating factor in this patient interferes with vascular adrenergic neurotransmission. Preincubation of porcine pulmonary artery vessel rings with patient plasma produced a dose-dependent inhibition of vasoconstriction to phenylephrine in vitro, abolished vasoconstriction to direct electrical stimulation, and had no effect on nonadrenergic vasoconstrictive stimuli (endothelin-1), PGF-2alpha (or KCl). Preincubation of vessels with control plasma was devoid of these effects. SOH plasma inhibited the binding of an alpha(1)-selective antagonist radioligand ([(125)I]HEAT) to membrane fractions derived from porcine pulmonary artery vessel rings, rat liver, and cell lines selectively overexpressing human ARs of the alpha(1B) subtype but not other AR subtypes (alpha(1A) and alpha(1D)). We conclude that a factor in SOH plasma can selectively and irreversibly inhibit adrenergic ligand binding to alpha(1B) ARs. We propose that this factor contributes to a novel pathogenesis for SOH in this patient. This patient's syndrome represents a new disease entity, and her plasma may provide a unique tool for probing the selective functions of alpha(1)-ARs.


Sujet(s)
Maladies du système nerveux autonome/physiopathologie , Protéines du sang/métabolisme , Hypotension orthostatique/physiopathologie , Antagonistes des récepteurs alpha-1 adrénergiques , Animaux , Maladies du système nerveux autonome/sang , Maladies du système nerveux autonome/diagnostic , Fixation compétitive/effets des médicaments et des substances chimiques , Dosage biologique , Protéines du sang/pharmacologie , Lignée cellulaire , Membrane cellulaire/métabolisme , Maladie chronique , Relation dose-effet des médicaments , Femelle , Humains , Hypotension orthostatique/sang , Hypotension orthostatique/diagnostic , Techniques in vitro , Contraction isométrique/effets des médicaments et des substances chimiques , Adulte d'âge moyen , Norépinéphrine/sang , Posture , Artère pulmonaire/effets des médicaments et des substances chimiques , Artère pulmonaire/métabolisme , Dosage par compétition , Rats , Récepteurs alpha-1 adrénergiques/métabolisme , Suidae , Tachycardie/étiologie , Vasoconstriction/effets des médicaments et des substances chimiques
9.
Genomics ; 58(1): 34-40, 1999 May 15.
Article de Anglais | MEDLINE | ID: mdl-10331943

RÉSUMÉ

Oculodentodigital dysplasia (ODDD) is an autosomal dominant condition with high penetrance and variable expressivity. The anomalies of the craniofacial region, eyes, teeth, and limbs indicate abnormal morphogenesis during early fetal development. Neurologic abnormalities occur later in life and appear to be secondary to white matter degeneration and basal ganglia changes. In familial cases, the dysmorphic and/or neurodegenerative components of the phenotype can be more severe and/or present at a younger age in subsequent generations, suggesting genetic anticipation. These clinical features suggest that the ODDD gene is pleiotropic with important functions throughout pre- and postnatal development. We have performed two-point linkage analysis with seven ODDD families and 19 microsatellite markers on chromosome 6q spanning a genetic distance of approximately 11 cM in males and 20 cM in females. We have refined the location of the ODDD gene between DNA markers D6S266/D6S261 (centromeric) and D6S1639 (telomeric), an interval of 1.01 (male) to 2.87 (female) cM. The strongest linkage was to DNA marker D6S433 (Zmax = 8.96, thetamax = 0.001). Families show significant linkage to chromosome 6q22-q23 and no evidence for genetic heterogeneity.


Sujet(s)
Malformations multiples/génétique , Chromosomes humains de la paire 6/génétique , ADN/génétique , Malformations multiples/anatomopathologie , Cartographie chromosomique , Malformations oculaires , Santé de la famille , Femelle , Liaison génétique , Marqueurs génétiques , Haplotypes , Humains , Lod score , Mâle , Nez/malformations , Odontodysplasie , Pedigree , Syndactylie , Langue/malformations
10.
J Biol Chem ; 272(48): 30380-6, 1997 Nov 28.
Article de Anglais | MEDLINE | ID: mdl-9374528

RÉSUMÉ

Tetanus toxin entry into vertebrate motorneurons may involve binding of neuronal surface gangliosides containing the "1b" substructure (a NeuAcalpha2,8NeuAc group on an internal galactose residue). The domains of tetanus toxin involved in ganglioside binding are known to reside within the carboxyl-terminal half of the toxin's heavy chain ("C fragment"). We developed a novel photoaffinity reagent based upon the structure of the 1b ganglioside GD1b (125I-azido-GD1b) to define the ganglioside-binding domains of tetanus toxin. Using this ligand, we observed radiolabeling of tetanus toxin C fragment which could be specifically inhibited by a ganglioside of the 1b series (GT1b), but not by a non-1b series ganglioside (GM3). When tetanus toxin C fragment was proteolyzed with clostripain, whether before or after reaction with 125I-azido-GD1b, a radiolabeled band was observed by SDS-polyacrylamide gel electrophoresis autoradiography, which was selectively inhibited by GT1b. Protein sequencing of proteolyzed tetanus toxin C fragment co-migrating with that band revealed the carboxyl-terminal 34 amino acid residues of tetanus toxin. Matrix-assisted laser desorption/ionization mass spectrometry of a photoaffinity labeled synthetic polypeptide representing the 34-amino acid domain revealed modification at a single residue (His1293). We propose that this domain of tetanus toxin is sufficient for ganglioside binding.


Sujet(s)
Gangliosides/composition chimique , Toxine tétanique/métabolisme , Marqueurs d'affinité , Séquence d'acides aminés , Azotures , Sites de fixation , Ligands , Spectrométrie de masse , Données de séquences moléculaires , Fragments peptidiques/composition chimique , Fragments peptidiques/métabolisme , Photochimie , Alignement de séquences , Similitude de séquences d'acides aminés
11.
Am J Med Genet ; 71(1): 36-41, 1997 Jul 11.
Article de Anglais | MEDLINE | ID: mdl-9215766

RÉSUMÉ

Oculodentodigital syndrome (O.D.) is an autosomal dominant disorder comprising facial anomalies, syndactyly, microcorneae, dental enamel hypoplasia, and leukodystrophy. We describe a four generation family with O.D. in which anomalies such as syndactyly appear congenitally, whereas neurological (i.e., leukodystrophic) signs and symptoms tend to be expressed in a more severe form and/or at an earlier age of onset in successive generations of the kindred. This pattern of phenotypic expression is consistent with the phenomenon of genetic anticipation, and we suggest that O.D. may be a trinucleotide repeat disorder.


Sujet(s)
Malformations multiples/génétique , Malformations multiples/épidémiologie , Malformations multiples/physiopathologie , Adulte , Âge de début , Malformations oculaires/génétique , Face/malformations , Femelle , Humains , Mâle , Maladies du système nerveux/épidémiologie , Maladies du système nerveux/génétique , Maladies du système nerveux/physiopathologie , Nez/malformations , Pedigree , Syndactylie/génétique , Syndrome , Malformations dentaires/génétique , Répétitions de trinucléotides
12.
Toxicol Appl Pharmacol ; 145(1): 61-7, 1997 Jul.
Article de Anglais | MEDLINE | ID: mdl-9221824

RÉSUMÉ

Isocyanates are used commercially, particularly in the manufacture of polyurethane coatings and foam. These compounds can pose an occupational health hazard since there is a risk of respiratory disease following isocyanate exposure. The purpose of the present study was to investigate whether a single, sublethal isocyanate inhalation is associated with increased production of the free radical nitric oxide (NO). Mature male Sprague-Dawley rats were exposed to air or toluene diisocyanate (TDI; 2 ppm) for 4 hr. Indices of pulmonary function were assessed before and after exposure to TDI fumes. At 20 hr postexposure, bronchoalveolar lavage cells (BALC) and fluid were harvested. NO synthase (NOS)-dependent reactive species production by alveolar macrophages was assessed by determining N(omega)-nitro-L-arginine methyl ester-inhibitable chemiluminescence following stimulation with unopsonized zymosan. Northern blot analysis was used to index inducible NOS mRNA levels in BALC, while nitrite and nitrate (NOx) levels were measured to determine NOx levels in the lavage fluid and the production of NO by cultured adherent BALC was indexed by measuring nitrite levels. Exposure to aerosolized TDI was associated with an increase in the number of alveolar macrophages, lymphocytes, and polymorphonuclear leukocytes harvested by bronchoalveolar lavage, relative to that from air-exposed rats. NOx levels in the lavage fluid and NOS-dependent production of reactive species by alveolar macrophages were increased following TDI exposure. In addition, inducible NO production by BALC (i.e., mRNA levels and nitrite levels in BALC conditioned media) was elevated following TDI treatment. These findings indicate that pulmonary inflammatory responses induced by TDI exposure are associated with increases in inducible NO production. Therefore, the potential role of NO in the initial pulmonary response to TDI exposure warrants further investigation.


Sujet(s)
Liquide de lavage bronchoalvéolaire/cytologie , Nitric oxide synthase/biosynthèse , Monoxyde d'azote/biosynthèse , 2,4-Diisocyanato-1-méthyl-benzène/toxicité , Administration par inhalation , Air , Animaux , Arginine/toxicité , Technique de Northern , Liquide de lavage bronchoalvéolaire/composition chimique , Cellules cultivées , Induction enzymatique/effets des médicaments et des substances chimiques , Inflammation/induit chimiquement , Mesures de luminescence , Macrophages alvéolaires/cytologie , Macrophages alvéolaires/effets des médicaments et des substances chimiques , Macrophages alvéolaires/métabolisme , Mâle , L-NAME/toxicité , ARN messager/métabolisme , Rats , Rat Sprague-Dawley , Espèces réactives de l'oxygène/métabolisme , Tests de la fonction respiratoire , 2,4-Diisocyanato-1-méthyl-benzène/administration et posologie , 2,4-Diisocyanato-1-méthyl-benzène/métabolisme , Zymosan/pharmacologie
13.
Proc Natl Acad Sci U S A ; 93(2): 814-8, 1996 Jan 23.
Article de Anglais | MEDLINE | ID: mdl-8570640

RÉSUMÉ

Nerve cells depend on specific interactions with glial cells for proper function. Myelinating glial cells are thought to associate with neuronal axons, in part, via the cell-surface adhesion protein, myelin-associated glycoprotein (MAG). MAG is also thought to be a major inhibitor of neurite outgrowth (axon regeneration) in the adult central nervous system. Primary structure and in vitro function place MAG in an immunoglobulin-related family of sialic acid-binding lactins. We report that a limited set of structurally related gangliosides, known to be expressed on myelinated neurons in vivo, are ligands for MAG. When major brain gangliosides were adsorbed as artificial membranes on plastic microwells, only GT1b and GD1a supported cell adhesion of MAG-transfected COS-1 cells. Furthermore, a quantitatively minor ganglioside expressed on cholinergic neurons, GQ1b alpha (also known as Chol-1 alpha-b), was much more potent than GT1b or GD1a in supporting MAG-mediated cell adhesion. Adhesion to either GT1b or GQ1b alpha was abolished by pretreatment of the adsorbed gangliosides with neuraminidase. On the basis of structure-function studies of 19 test glycosphingolipids, an alpha 2,3-N-acetylneuraminic acid residue on the terminal galactose of a gangliotetraose core is necessary for MAG binding, and additional sialic acid residues linked to the other neutral core saccharides [Gal(II) and GalNAc(III)] contribute significantly to binding affinity. MAG-mediated adhesion to gangliosides was blocked by pretreatment of the MAG-transfected COS-1 cells with anti-MAG monoclonal antibody 513, which is known to inhibit oligodendrocyte-neuron binding. These data are consistent with the conclusion that MAG-mediated cell-cell interactions involve MAG-ganglioside recognition and binding.


Sujet(s)
Adhérence cellulaire/physiologie , Gangliosides/métabolisme , Glycoprotéine associée à la myéline/métabolisme , Neurones/physiologie , Animaux , Séquence glucidique , Cellules cultivées , Isomérie , Ligands , Données de séquences moléculaires , Glycoprotéine associée à la myéline/génétique , Acide N-acétyl-neuraminique , Protéines recombinantes/métabolisme , Acides sialiques/métabolisme , Relation structure-activité , Transfection
15.
J Comp Neurol ; 238(4): 473-88, 1985 Aug 22.
Article de Anglais | MEDLINE | ID: mdl-3840183

RÉSUMÉ

We employed the neural tracers cholera toxin-horseradish peroxidase and wheat germ agglutinin-horseradish peroxidase to examine the organization of the afferent and efferent connections of the stomach within the medulla oblongata of the rat. The major finding of this study is that gastric motoneurons of the dorsal motor nucleus (DMN) possess numerous dendrites penetrating discrete regions of the overlying nucleus of the solitary tract (NTS). In particular, dendritic labelling was present in areas of NTS which also received terminals of gastric vagal afferent fibers such as the subnucleus gelatinosus, nucleus commissuralis, and medial nucleus of NTS. This codistribution of afferent and efferent elements of the gastric vagus may provide loci for monosynaptic vagovagal interactions. A small number of dendrites of DMN neurons penetrated the ependyma of the fourth ventricle and a few others entered the ventral aspect of the area postrema, thus making possible the direct contact of preganglionic neurons with humoral input from the cerebrospinal fluid and/or the peripheral plasma. Nucleus ambiguus neurons projecting to the stomach predominantly innervate the forestomach. The dendrites of these cells, when labelled, were generally short, and extended beyond the compact cluster of ambiguus neurons in a ventrolateral direction, parallel to the fascicles of vagal efferent fibers traversing the medulla.


Sujet(s)
Moelle allongée/cytologie , Estomac/innervation , Nerf vague/anatomie et histologie , Voies afférentes/cytologie , Animaux , Tronc cérébral/cytologie , Toxine cholérique , Dendrites/analyse , Voies efférentes/cytologie , Horseradish peroxidase , Lectines , Microinjections , Rats , Lignées consanguines de rats , Facteurs temps , Agglutinines germe blé
16.
J Comp Neurol ; 234(3): 344-64, 1985 Apr 15.
Article de Anglais | MEDLINE | ID: mdl-3988989

RÉSUMÉ

We applied the neuroanatomical tracers cholera toxin-horseradish peroxidase and wheat germ agglutinin-horseradish peroxidase to investigate the neural connections of the area postrema (AP) in the rat. We find that the AP projects to the nucleus of the solitary tract (NTS) and dorsal motor nucleus of the vagus bilaterally both rostral and caudal to obex; the nucleus ambiguus; the dorsal aspect of the spinal trigeminal tract and nucelus and the paratrigeminal nucleus; the region of the ventrolateral medullary catecholaminergic column; the cerebellar vermis; and a cluster of structures in the dorsolateral pons which prominently include a discrete set of subnuclei in the lateral parabrachial nucleus. The major central afferent input to the area postrema is provided by a group of neurons in the paraventricular and dorsomedial hypothalamic nuclei whose collective dendrites describe a horizontally oriented plexus which encircles the parvocellular nucleus of the hypothalamus bilaterally. In addition, the caudal NTS may project lightly to the AP. The lateral parabrachial nucleus provides a very light input as well. These connections, when considered in the context of the known vagal afferent input and reduced blood-brain barrier of AP, place this structure in a unique position to receive and modulate ascending interoceptive information and to influence autonomic outflow as well.


Sujet(s)
Ventricules cérébraux/anatomie et histologie , Moelle allongée/anatomie et histologie , Voies afférentes/anatomie et histologie , Animaux , Axones/ultrastructure , Dendrites/ultrastructure , Voies efférentes/anatomie et histologie , Neurofibres/ultrastructure , Neurones/ultrastructure , Noyau paraventriculaire de l'hypothalamus/anatomie et histologie , Pont/anatomie et histologie , Rats , Lignées consanguines de rats , Formation réticulaire/anatomie et histologie , Moelle spinale/anatomie et histologie , Nerf vague/anatomie et histologie
17.
Fed Proc ; 43(15): 2969-71, 1984 Dec.
Article de Anglais | MEDLINE | ID: mdl-6500071

RÉSUMÉ

Lesions of the area postrema (AP) and immediately adjacent nucleus tractus solitarii cause a syndrome of permanent weight loss with little disruption to behavioral controls of body weight regulation. There is also a permanent polydipsia and elevated salt appetite, which appear to be secondary to deficits in renal conservation of water and sodium. Neuroanatomical studies indicate that the immediately adjacent solitary nucleus and AP are sites of termination of visceral afferents from abdominal organs and the destination and origin of distant central afferent and efferent connections.


Sujet(s)
Poids , Ventricules cérébraux/physiologie , Moelle allongée/physiologie , Équilibre hydroélectrolytique , Animaux , Ventricules cérébraux/anatomie et histologie , Comportement dipsique/physiologie , Comportement alimentaire/physiologie , Rein/physiologie , Moelle allongée/anatomie et histologie , Voies nerveuses , Rats
18.
Fundam Appl Toxicol ; 2(2): 55-66, 1982.
Article de Anglais | MEDLINE | ID: mdl-6764428

RÉSUMÉ

Substances that cause liver damage in humans were identified through a literature search conducted on Toxline and Medline. Using the same search strategy, species other than man were selected, in whom hepatic injury could be attributed to exposure to the identified substances. A total of 38 substances were identified as producing liver damage, manifested by either clinical chemistry or histopathology. The substances included 24 drugs, 9 industrial chemicals, 3 environmental agents, 1 pesticide, and ethanol. Twelve of the 36 compounds have been toxicologically evaluated in man, rodent, and non-rodent. Histopathologic liver damage was reported in all three species for 11 of these compounds. Only carbencillin produced histopathologic damage in man but not in either the rodent or non-rodent. Where clinical chemistry changes were reported for all three species categories, only eight substances induced similar reactions in all three species. Only with two substances did man and rodent react similarly (both positive), while the non-rodent was negative. The two substances were polychlorinated biphenyl (PCB) and tetrachlorethane. In the majority of the cases in which either or both histopathologic or clinical chemistry changes were reported for man or for the rodent or non-rodent, the changes that occurred were qualitatively similar. The rodent was as sensitive a predictor for hepatic effects as the non-rodent. Although it is impossible to predict how liver damage observed in a laboratory animal is correlated with human liver damage, hepatotoxicity in the rodent must be considered as indicative of potential hepatic damage in man.


Sujet(s)
Lésions hépatiques dues aux substances/étiologie , Effets secondaires indésirables des médicaments , Foie/effets des médicaments et des substances chimiques , Animaux , Humains , Rats
19.
Science ; 205(4410): 1022-5, 1979 Sep 07.
Article de Anglais | MEDLINE | ID: mdl-472723

RÉSUMÉ

The subfornical organ, a circumventricular structure of the central nervous system, has efferent neural projections to sites within the brain known to be involved in drinking behavior and secretion of antidiuretic hormone. By using anterograde tracing techniques, it is shown that the subfornical organ projects to the nucleus medians of the medial preoptic area, to the organum vasculosum of the lamina terminalis, and to the supraoptic nuclei bilaterally. Its efferent connectivity is confirmed by retrograde transport of horseradish peroxidase. The organum vasculosum of the lamina terminalis, another circumventricular organ and a suspected receptor site for angiotensin II, is involved in the circuitry of the subfornical organ and also has an efferent projection to the supraoptic nuclei.


Sujet(s)
Ventricules cérébraux/cytologie , Système neuroendocrinien/physiologie , Organe subfornical/physiologie , Équilibre hydroélectrolytique , Animaux , Encéphale/cytologie , Comportement dipsique/physiologie , Voies efférentes/physiologie , Mâle , Aire préoptique/cytologie , Rats , Organe subfornical/cytologie , Noyau supraoptique/cytologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE